GSK3B and Alzheimer disease: Previous studies have reported that the levels of PI3K subunits (both p85 and p110) and phosphorylations of Akt at the Ser473 site and GSK-3β at the Ser9 site are decreased in the postmortem AD brain samples [65, 66].